SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062103
Filing Date
2023-11-09
Accepted
2023-11-09 16:20:57
Documents
91
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fdmt-20230930.htm   iXBRL 10-Q 3268530
2 EX-10.1 fdmt-ex10_1.htm EX-10.1 913887
3 EX-31.1 fdmt-ex31_1.htm EX-31.1 21473
4 EX-31.2 fdmt-ex31_2.htm EX-31.2 21399
5 EX-32.1 fdmt-ex32_1.htm EX-32.1 13248
6 GRAPHIC img29553951_0.jpg GRAPHIC 5688
7 GRAPHIC img29553951_1.jpg GRAPHIC 199079
  Complete submission text file 0000950170-23-062103.txt   12913447

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fdmt-20230930_pre.xml EX-101.PRE 446996
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fdmt-20230930_cal.xml EX-101.CAL 47166
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fdmt-20230930_def.xml EX-101.DEF 302994
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fdmt-20230930_lab.xml EX-101.LAB 576037
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fdmt-20230930.xsd EX-101.SCH 82845
85 EXTRACTED XBRL INSTANCE DOCUMENT fdmt-20230930_htm.xml XML 2145265
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39782 | Film No.: 231392824
SIC: 2836 Biological Products, (No Diagnostic Substances)